Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03KVY
|
||||
| Former ID |
DIB006058
|
||||
| Drug Name |
BCT303
|
||||
| Synonyms |
Liothyronine sustained release
|
||||
| Indication | Hypothyroidism [ICD9: 244; ICD10:E03] | Phase 2 | [1] | ||
| Company |
Intellectual property executives
|
||||
| Target and Pathway | |||||
| Target(s) | Thyroid hormone receptor alpha | Target Info | Modulator | [2] | |
| Thyroid hormone receptor beta-1 | Target Info | Modulator | [2] | ||
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Thyroid hormone signaling pathwayhsa04080:Neuroactive ligand-receptor interaction | |||||
| Thyroid hormone signaling pathway | |||||
| Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptorrxr_vdr_pathway:RXR and RAR heterodimerization with other nuclear receptor | ||||
| Reactome | Nuclear Receptor transcription pathwayR-HSA-383280:Nuclear Receptor transcription pathway | ||||
| WikiPathways | Endochondral Ossification | ||||
| Nuclear ReceptorsWP706:SIDS Susceptibility Pathways | |||||
| Hematopoietic Stem Cell Differentiation | |||||
| Nuclear Receptors | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037654) | ||||
| REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.